Tandem Diabetes Care, Inc. Cost of Revenue
Tandem Diabetes Care, Inc. (TNDM) reported Cost of Revenue of $109.78 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-06
- Tandem Diabetes Care, Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $109.78M, a 4.39% decline year-over-year.
- Tandem Diabetes Care, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $110.43M, a 4.81% decline year-over-year.
- Tandem Diabetes Care, Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $122.92M, a 1.81% decline year-over-year.
- Tandem Diabetes Care, Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $114.96M, a 3.65% decline year-over-year.
- Tandem Diabetes Care, Inc. cost of goods and services sold for fiscal 2025 was $468.72M, a 4.02% increase from fiscal 2024.
- Tandem Diabetes Care, Inc. cost of goods and services sold for fiscal 2024 was $450.63M, a 18.58% increase from fiscal 2023.
- Tandem Diabetes Care, Inc. cost of goods and services sold for fiscal 2023 was $380.03M, a 2.11% decline from fiscal 2022.
- Tandem Diabetes Care, Inc. cost of goods and services sold for fiscal 2022 was $388.23M, a 18.88% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $109.78M 10-Q · filed 2026-08-06 | $220.21M 10-Q · filed 2026-08-06 | $343.14M derived: sum of 3 quarters · filed 2026-08-06 | $458.10M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $110.43M 10-Q · filed 2026-05-07 | $233.36M derived: sum of 2 quarters · filed 2026-05-07 | $348.32M derived: sum of 3 quarters · filed 2026-05-07 | $463.14M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $122.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $237.88M derived: sum of 2 quarters · filed 2026-02-19 | $352.71M derived: sum of 3 quarters · filed 2026-08-06 | $468.72M 10-K · filed 2026-02-19 | |||
| 2025-09-30 | $114.96M 10-Q · filed 2025-11-06 | $229.78M derived: sum of 2 quarters · filed 2026-08-06 | $345.80M 10-Q · filed 2025-11-06 | $470.99M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $114.82M 10-Q · filed 2026-08-06 | $230.84M 10-Q · filed 2026-08-06 | $356.03M derived: sum of 3 quarters · filed 2026-08-06 | $475.35M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $116.02M 10-Q · filed 2026-05-07 | $241.21M derived: sum of 2 quarters · filed 2026-05-07 | $360.53M derived: sum of 3 quarters · filed 2026-05-07 | $469.64M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $125.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $244.51M derived: sum of 2 quarters · filed 2026-02-19 | $353.63M derived: sum of 3 quarters · filed 2026-02-19 | $450.63M 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $119.32M 10-Q · filed 2025-11-06 | $228.43M derived: sum of 2 quarters · filed 2025-11-06 | $325.44M 10-Q · filed 2025-11-06 | $428.94M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-06-30 | $109.12M 10-Q · filed 2025-08-06 | $206.12M 10-Q · filed 2025-08-06 | $309.62M derived: sum of 3 quarters · filed 2026-02-19 | $405.49M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-03-31 | $97.00M 10-Q · filed 2025-04-30 | $200.50M derived: sum of 2 quarters · filed 2026-02-19 | $296.37M derived: sum of 3 quarters · filed 2026-02-19 | $390.55M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2023-12-31 | $103.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $199.37M derived: sum of 2 quarters · filed 2026-02-19 | $293.55M derived: sum of 3 quarters · filed 2026-02-19 | $380.03M 10-K · filed 2026-02-19 | |||
| 2023-09-30 | $95.87M 10-Q · filed 2024-11-06 | $190.05M derived: sum of 2 quarters · filed 2024-11-06 | $276.53M 10-Q · filed 2024-11-06 | $381.51M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-06-30 | $94.18M 10-Q · filed 2024-08-01 | $180.66M 10-Q · filed 2024-08-01 | $285.64M derived: sum of 3 quarters · filed 2025-02-26 | $385.76M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-03-31 | $86.48M 10-Q · filed 2024-05-02 | $191.46M derived: sum of 2 quarters · filed 2025-02-26 | $291.58M derived: sum of 3 quarters · filed 2025-02-26 | $389.89M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2022-12-31 | $104.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $205.10M derived: sum of 2 quarters · filed 2025-02-26 | $303.42M derived: sum of 3 quarters · filed 2025-02-26 | $388.23M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $100.12M 10-Q · filed 2023-11-01 | $198.44M derived: sum of 2 quarters · filed 2023-11-01 | $283.25M 10-Q · filed 2023-11-01 | $379.52M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | $98.32M 10-Q · filed 2023-08-03 | $183.13M 10-Q · filed 2023-08-03 | $279.40M derived: sum of 3 quarters · filed 2024-02-21 | $362.28M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | $84.81M 10-Q · filed 2023-05-03 | $181.08M derived: sum of 2 quarters · filed 2024-02-21 | $263.96M derived: sum of 3 quarters · filed 2024-02-21 | $343.65M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | $96.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $179.15M derived: sum of 2 quarters · filed 2024-02-21 | $258.83M derived: sum of 3 quarters · filed 2024-02-21 | $326.58M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $82.88M 10-Q · filed 2022-11-02 | $162.57M derived: sum of 2 quarters · filed 2022-11-02 | $230.32M 10-Q · filed 2022-11-02 | $307.83M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-06-30 | $79.69M 10-Q · filed 2022-08-03 | $147.44M 10-Q · filed 2022-08-03 | $224.94M derived: sum of 3 quarters · filed 2023-02-22 | $283.23M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-03-31 | $67.75M 10-Q · filed 2022-05-04 | $145.26M derived: sum of 2 quarters · filed 2023-02-22 | $203.55M derived: sum of 3 quarters · filed 2023-02-22 | $258.39M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2020-12-31 | $77.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $135.80M derived: sum of 2 quarters · filed 2023-02-22 | $190.65M derived: sum of 3 quarters · filed 2023-02-22 | $238.31M 10-K · filed 2023-02-22 | |||
| 2020-09-30 | $58.29M 10-Q · filed 2021-11-03 | $113.14M derived: sum of 2 quarters · filed 2021-11-03 | $160.80M 10-Q · filed 2021-11-03 | $208.93M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-06-30 | $54.85M 10-Q · filed 2021-08-04 | $102.51M 10-Q · filed 2021-08-04 | $150.64M derived: sum of 3 quarters · filed 2022-02-22 | $194.61M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-03-31 | $47.66M 10-Q · filed 2021-05-05 | $95.79M derived: sum of 2 quarters · filed 2022-02-22 | $139.76M derived: sum of 3 quarters · filed 2022-02-22 | $183.12M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2019-12-31 | $48.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $92.10M derived: sum of 2 quarters · filed 2022-02-22 | $135.45M derived: sum of 3 quarters · filed 2022-02-22 | $168.09M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | $43.97M 10-Q · filed 2020-11-05 | $87.33M derived: sum of 2 quarters · filed 2020-11-05 | $119.97M 10-Q · filed 2020-11-05 | $154.63M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-06-30 | $43.35M 10-Q · filed 2020-07-30 | $75.99M 10-Q · filed 2020-07-30 | $110.66M derived: sum of 3 quarters · filed 2021-02-24 | $135.12M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-03-31 | $32.64M 10-Q · filed 2020-04-30 | $67.31M derived: sum of 2 quarters · filed 2021-02-24 | $91.77M derived: sum of 3 quarters · filed 2021-02-24 | $110.81M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | $34.66M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $59.13M derived: sum of 2 quarters · filed 2021-02-24 | $78.17M derived: sum of 3 quarters · filed 2021-02-24 | $94.04M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $24.47M 10-Q · filed 2019-11-04 | $43.51M derived: sum of 2 quarters · filed 2019-11-04 | $59.38M 10-Q · filed 2019-11-04 | $82.21M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-06-30 | $19.04M 10-Q · filed 2019-08-01 | $34.91M 10-Q · filed 2019-08-01 | $57.74M derived: sum of 3 quarters · filed 2020-02-24 | $72.87M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-03-31 | $15.87M 10-Q · filed 2019-04-30 | $38.70M derived: sum of 2 quarters · filed 2020-02-24 | $53.83M derived: sum of 3 quarters · filed 2020-02-24 | $67.16M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | $22.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $37.96M derived: sum of 2 quarters · filed 2020-02-24 | $51.28M derived: sum of 3 quarters · filed 2020-02-24 | $63.51M 10-K · filed 2020-02-24 | |||
| 2017-09-30 | $15.13M 10-Q · filed 2018-11-01 | $28.46M derived: sum of 2 quarters · filed 2018-11-01 | $40.68M 10-Q · filed 2018-11-01 | $59.53M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | $13.32M 10-Q · filed 2018-07-30 | $25.55M 10-Q · filed 2018-07-30 | $44.40M derived: sum of 3 quarters · filed 2019-02-26 | $58.27M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | $12.22M 10-Q · filed 2018-04-26 | $31.07M derived: sum of 2 quarters · filed 2019-02-26 | $44.94M derived: sum of 3 quarters · filed 2019-02-26 | $59.75M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $18.85M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $32.72M derived: sum of 2 quarters · filed 2019-02-26 | $47.53M derived: sum of 3 quarters · filed 2019-02-26 | $60.66M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $13.87M 10-Q · filed 2017-10-26 | $28.68M derived: sum of 2 quarters · filed 2017-10-26 | $41.81M 10-Q · filed 2017-10-26 | $57.47M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $14.81M 10-Q · filed 2017-07-27 | $27.94M 10-Q · filed 2017-07-27 | $43.60M derived: sum of 3 quarters · filed 2018-03-01 | $53.80M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | $13.13M 10-Q · filed 2017-04-27 | $28.79M derived: sum of 2 quarters · filed 2018-03-01 | $38.99M derived: sum of 3 quarters · filed 2018-03-01 | $49.90M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $15.66M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $25.86M derived: sum of 2 quarters · filed 2018-03-01 | $36.77M derived: sum of 3 quarters · filed 2018-03-01 | $46.27M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | $10.20M 10-Q · filed 2016-11-01 | $21.11M derived: sum of 2 quarters · filed 2016-11-01 | $30.61M 10-Q · filed 2016-11-01 | $41.96M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-06-30 | $10.90M 10-Q · filed 2016-07-28 | $20.41M 10-Q · filed 2016-07-28 | $31.76M derived: sum of 3 quarters · filed 2017-03-08 | $40.88M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-03-31 | $9.50M 10-Q · filed 2016-04-28 | $20.85M derived: sum of 2 quarters · filed 2017-03-08 | $29.97M derived: sum of 3 quarters · filed 2017-03-08 | $36.78M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2014-12-31 | $11.35M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $20.47M derived: sum of 2 quarters · filed 2017-03-08 | $27.28M derived: sum of 3 quarters · filed 2017-03-08 | $34.47M 10-K · filed 2017-03-08 | |||
| 2014-09-30 | $9.12M 10-Q · filed 2015-10-29 | $9.12M 10-Q · filed 2014-11-06 | $15.92M derived: sum of 2 quarters · filed 2015-10-29 | $23.12M 10-Q · filed 2015-10-29 | $23.12M 10-Q · filed 2014-11-06 | $32.18M derived: sum of 4 quarters · filed 2016-02-24 | |
| 2014-06-30 | $6.81M 10-Q · filed 2014-07-31 | $14.01M 10-Q · filed 2015-07-30 | $14.00M 10-Q · filed 2014-07-31 | $23.06M derived: sum of 3 quarters · filed 2016-02-24 | $28.31M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-31 | $7.20M 10-Q · filed 2015-04-30 | $7.20M 10-Q · filed 2014-05-06 | $16.26M derived: sum of 2 quarters · filed 2016-02-24 | $21.50M derived: sum of 3 quarters · filed 2016-02-24 | $26.62M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2013-12-31 | $9.06M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $14.30M derived: sum of 2 quarters · filed 2016-02-24 | $19.42M derived: sum of 3 quarters · filed 2016-02-24 | $22.84M 10-K · filed 2016-02-24 | |||
| 2013-09-30 | $5.24M 10-Q · filed 2014-11-06 | $10.37M derived: sum of 2 quarters · filed 2014-11-06 | $13.78M 10-Q · filed 2014-11-06 | ||||
| 2013-06-30 | $5.12M 10-Q · filed 2014-07-31 | $8.54M 10-Q · filed 2014-07-31 | |||||
| 2013-03-31 | $3.42M 10-Q · filed 2014-05-06 | ||||||
| 2012-12-31 | $3.82M 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |